Lilly Unveils Ambitious Partnership for Tuberculosis Drug Discovery
Seattle, WA – Eli Lilly and Company (NYSE: LLY) today announced the creation of an ambitious public-private partnership to conduct
Seattle, WA – Eli Lilly and Company (NYSE: LLY) today announced the creation of an ambitious public-private partnership to conduct
SEATTLE, June 13 (Reuters) – Eli Lilly and Co. has joined forces with U.S. health experts in the search for
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of
With the whole world wagging its collective finger at Andrew Speaker–the TB-infected lawyer who triggered a global health scare last
Dr. Sanjay Gupta, CNN Chief Medical Correspondent (LIVE) I’m Dr. Sanjay Gupta, and this is a special edition of HOUSECALL
To those for whom tuberculosis is largely consigned to the early 19th century, a WHO estimate that one-third of the
New York – The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery
A range of promising new tools to prevent, detect and cure tuberculosis (TB), which kills some 1.6 million people globally
SAN FRANCISCO – Saying there “couldn’t be a better time” for biotechnology, Chiron Corp.’s co-founder William Rutter told first-day attendees
BG Medicine provides information on its latest news and research developments. This trend article is an immediate alert from NewsRx